"Seed-To-Sale" Saturday Update: Only 2 Stocks Are Up YTD

The munKNEE Pure-Play "Seed-to-Sale" Pot Stocks Index:

  • went DOWN -12.6% last week and
  • is now DOWN -13.7% so far in January and 
  • is now DOWN -65.6% from its 52-week high with
  • with the Canadian LPs segment going DOWN -14.9% last week (-16.5% YTD) and
  • the American MSOs segment going DOWN -12.2% (-13.1%).

The munKNEE "Seed-to-Sale" Pot Stocks Index consists of:

  • the 21 non-ancillary (i.e. pure-play) vertically integrated cannabis companies whose stocks trade for at least US$1/share (4Front Ventures is the only exception), have a market cap of at least US$200M and trade on one or more of the Canadian and/or American stock exchanges made up of:
    • 5 Canadian Licensed Producers (LPs) and
    • 16 American Multi-State Operators (MSOs) which, in total,
    • represent 10% of the total universe of 211 cannabis and ancillary companies currently trading.

The non-tradable Index gives each constituent the same importance to provide a comparison of the performance of each with the others and the stated sector as a whole.

Below are the specifics by constituent per sector:

The munKNEE Pure-Play Canadian LP Pot Stock Index

Note that each constituent has 5 areas of additional information that are imperative for any individual considering investing in this sector:

  1. The company name is hyperlinked to its web site to provide you with a description of the company and an analysis of its stock.
  2. The trading symbol is hyperlinked to additional financial data and commentary on the company (where available).
  3. The "financial distress" percentage is sourced from macroaxis.com (visit the site and type in the stock symbol to obtain detailed financial data on the health of the company).
  4. The percentage change is hyperlinked to a chart of the company's stock performance.
  5. The articles hyperlinked are sourced from Stone Fox Capital and/or Technical420 and provide analyses/commentaries on most of the constituents below to help a potential investor with insights into the burgeoning, yet volatile, cannabis sector.

Below is how the Canadian Licensed Producer constituents have performed so far in January, in descending order:

  1. Cronos (CRON): -12.5%
  2. Canopy Growth (CGC): -16.5%
  3. Aurora (ACB): -17.6% 
  4. Tilray (TLRY): -17.6% 
  5. Organigram (OGI): -6.3%

The munKNEE Pure-Play American MSO Pot Stock Index 

Below is how the American Multi-State Operator constituents have performed so far in January, in descending order:

  1. Jushi (JUSHF): +12.0%
  2. Columbia Care (CCHWF): +1.4%
  3. Ayr Wellness (AYRWF): -1.6%
  4. Goodness Growth (GDNSF): -1.8%
    • Has more than 63% chance of experiencing financial distress in the next few years of operation
  5. Planet 13 (PLNHF): -5.1%
    • Has about a 25% chance of experiencing some form of financial distress in the next two years of operation
  6. Acreage (ACRDF/ACRHF): -10.5%
  7. Cresco (CRLBF): -12.3%
  8. Verano (VRNOF): -13.1%
  9. Green Thumb (GTBIF): -13.9%
  10. Curaleaf (CURLF): -15.6%
  11. TerrAscend (TRSSF): -18.3%
  12. Gage Growth (GAEGF): -19.0% 
    • in the process of being acquired by TerrAscend (TRSSF)
  13. Trulieve (TCNNF): -19.5%
  14. 4Front Ventures (FFNTF): -21.8%
  15. Valens (VLNS): -26.9.0%
    • Has a 50% chance of going through some form of financial distress in the next two years
  16. Ascend Wellness (AAWH): -25.0%

The performance of our Pure-play "Seed-to-Sale" Index has been atrocious over the past 52 weeks and is showing no sign of improving based on the -13.7% decline YTD. 

Visit  munKNEE.com and register to receive our free Market Intelligence Report newsletter (sample  more

How did you like this article? Let us know so we can better customize your reading experience.